Percutaneous coronary intervention with drug-eluting stent implantation vs. coronary artery bypass grafting for multivessel coronary artery disease in metabolic syndrome patients with acute myocardial infarction

Circulation Journal

Volumn 76, Issue 3, 2012, Pages 721-728

  Ahmed, Khurshid ^a,e   Jeong, Myung Ho ^a   Chakraborty, Rabin ^e   Hong, Young Joon ^a   Sim, Doo Sun ^a   Hwang, Seung Hwan ^a   Lee, Min Goo ^a   Park, Keun Ho ^a   Kim, Ju Han ^a   Ahn, Youngkeun ^a   Cho, Myeong Chan ^b   Kim, Chong Jin ^c   Kim, Young Jo ^d   Park, Jong Chun ^a   Kang, Jung Chaee ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chungbuk National University Hospital   (South Korea)

^c Kyung Hee University College of Medicine   (South Korea)

^d Young Nam University Hospital   (South Korea)

^e Apollo Gleneagles Hospital   (India)

Author keywords

Coronary angioplasty; Coronary artery bypass; Metabolic syndrome X; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PACLITAXEL; RAPAMYCIN; STATIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE FREE SURVIVAL; DRUG ELUTING STENT; FEMALE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84863229539     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-1013     Document Type: Article

References (31)

1. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, et al. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 2008; 117: 2079-2086.
2. Hannan EL, Wu C, Walford G, Culliford AT, Gold JP, Smith CR, et al. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 2008; 358: 331-341.
3. Varani E, Balducelli M, Vecchi G, Aquilina M, Maresta A. Comparison of multiple drug-eluting stent percutaneous coronary intervention and surgical revascularization in patients with multivessel coronary artery disease: One-year clinical results and total treatment costs. J Invasive Cardiol 2007; 19: 469-475.
4. Javaid A, Steinberg DH, Buch AN, Corso PJ, Boyce SW, Pinto Slottow TL, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation 2007; 116: I200-I206.
5. Benedetto U, Melina G, Angeloni E, Refice S, Roscitano A, Fiorani B, et al. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease: A meta-analysis on 24,268 patients. Eur J Cardiothorac Surg 2009; 36: 611-615.
6. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, et al. The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. J Am Coll Cardiol 2010; 56: 1113-1132.
7. Kim KS. PCI vs CABG in complicated diabetic patients: Do we need more data to change the practical guideline? Circ J 2010; 74: 622-623.
8. Takayama T, Hiro T, Hirayama A. Is angioplasty able to become the gold standard of treatment beyond bypass surgery for patients with multivessel coronary artery disease? Therapeutic strategies for 3-vessel coronary artery disease: OPCAB vs PCI (PCI-Side). Circ J 2010; 74: 2744-2749.
9. Wang ZJ, Zhou YJ, Liu YY, Shi DM, Zhao YX, Guo YH, et al. Comparison of drug-eluting stents and coronary artery bypass grafting for the treatment of multivessel coronary artery disease in patients with chronic kidney disease. Circ J 2009; 73: 1228-1234.
10. Chiu FC, Chang SN, Lin JW, Hwang JJ, Chen YS. Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: A propensity score analysis. J Thorac Cardiovasc Surg 2009; 138: 1326-1330.
11. Sim DS, Jeong MH, Kang JC. Current management of acute myocardial infarction: Experience from the Korea Acute Myocardial Infarction Registry. J Cardiol 2010; 56: 1-7.
12. Lee SR, Jeong MH, Ahn YK, Chae SC, Hur SH, Kim YJ, et al. Clinical safety of drug-eluting stents in the Korea Acute Myocardial Infarction Registry. Circ J 2008; 72: 392-398.
13. Park KH, Jeong MH, Lee MG, Ko JS, Lee SE, Kang WY, et al. Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation. Korean Circ J 2009; 39: 190-197.
14. Apple FS, Wu AH, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: How to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-986.
15. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
16. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 2004; 110: e340-e437.
17. Lauer MS, Blackstone EH, Young JB, Topol EJ. Cause of death in clinical research: Time for a reassessment? J Am Coll Cardiol 1999; 34: 618-620.
18. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: A prospective study. Lancet 2002; 359: 2140-2144.
19. Ito H. Optimal treatment for coronary artery disease in patients with diabetes: Percutaneous coronary intervention, coronary artery bypass graft, and medications. Gen Thorac Cardiovasc Surg 2011; 59: 6-13.
20. Grundy SM. Metabolic syndrome: A multiplex cardiovascular risk factor. J Clin Endocrinol Metab 2007; 92: 399-404.
21. Johnson LW, Weinstock RS. The metabolic syndrome: Concepts and controversy. Mayo Clin Proc 2006; 81: 1615-1620.
22. Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, et al. Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus. Am J Cardiol 2006; 97: 236-239.
23. Rodriguez AE, Grinfeld L, Fernandez-Pereira C, Mieres J, Rodriguez Alemparte M, Berrocal D, et al. Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: One year follow-up results of the ERACI III Trial. EuroIntervention 2006; 2: 53-60.
24. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
25. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A singlecenter experience. Circulation 2006; 113: 2542-2547.
26. Serruys PW, Ong AT, Morice MC, De Bruyne B, Colombo A, Macaya C, et al. Arterial Revascularisation Therapies Study Part II: Sirolimus- eluting stents for the treatment of patients with multivessel de novo coronary artery lesions. EuroIntervention 2005; 1: 147-156.
27. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961-972.
28. Aronson D, Bloomgarden Z, Rayfield EJ. Potential mechanisms promoting restenosis in diabetic patients. J Am Coll Cardiol 1996; 27: 528-535.
29. Moreno R, Fernandez C, Hernandez R, Alfonso F, Angiolillo DJ, Sabate M, et al. Drug-eluting stent thrombosis: Results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005; 45: 954-959.
30. Widimsky P, Holmes DR Jr. How to treat patient with ST-elevation acute myocardial infarction and multi-vessel disease? Eur Heart J 2011; 32: 396-403.
31. Gu YL, van der Horst IC, Douglas YL, Svilaas T, Mariani MA, Zijlstra F. Role of coronary artery bypass grafting during the acute and subacute phase of ST-elevation myocardial infarction. Neth Heart J 2010; 18: 348-354.